Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Lisa Brownlee"'
Autor:
Bernard Séguin, Lisa Brownlee
Publikováno v:
Veterinary Surgical Oncology. :569-623
Autor:
Elizabeth A. Atencio, Lisa Brownlee, Jacqueline D. Murphy, Daniel L. Gustafson, Katherine A. Stroda, Ryan J. Hansen, Susan E. Lana
Publikováno v:
American Journal of Veterinary Research. 78:862-866
OBJECTIVE To characterize pharmacokinetics of cyclophosphamide and 4-hydoxycyclophosphamide (4-OHCP) in the plasma of healthy cats after oral, IV, and IP administration of cyclophosphamide. ANIMALS 6 healthy adult cats. PROCEDURES Cats were randomly
Autor:
Carol R. Reinero, Lisa Brownlee, Kendra C. Decile, Bernard Seguin, Roy D. Berghaus, Richard W. Nelson, Laurel J. Gershwin
Publikováno v:
Journal of Veterinary Internal Medicine. 20:57-64
Autor:
Lisa Brownlee
Publikováno v:
Advances in Small Animal Medicine and Surgery. 24:1-3
Publikováno v:
Journal of Veterinary Internal Medicine. 14:412-417
Autor:
John E. Mata, Jennifer M. Simpson, Bernard Séguin, Kevin Marley, William G. Tracewell, Stuart C. Helfand, Shay Bracha, Lisa Brownlee
Publikováno v:
Journal of Experimental & Clinical Cancer Research : CR
Background Osteosarcoma in dogs and humans share many similarities and the dog has been described as an excellent model to study this disease. The median survival in dogs has not improved in the last 25 years. Taurolidine has been shown to be cytotox
Publikováno v:
Veterinary Surgical Oncology ISBN: 9781118729038
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f8b17fe913e3da96bf00253fd8c2ff3c
https://doi.org/10.1002/9781118729038.ch13
https://doi.org/10.1002/9781118729038.ch13
Autor:
Carol R, Reinero, Lisa, Brownlee, Kendra C, Decile, Bernard, Seguin, Roy D, Berghaus, Richard W, Nelson, Laurel J, Gershwin
Publikováno v:
Journal of veterinary internal medicine. 20(1)
Feline bronchial disease is commonly treated with oral glucocorticoids (OGC), which might be contraindicated in cats with certain infectious, endocrine, renal, or cardiac diseases. Inhalant GC (IGC) maximize local efficacy and minimize systemic bioav